Security Reports > Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc
Data Breaches, Cyber Attacks and Security Report  ᛫  Biotech & Pharmaceuticals
Last updated August 15, 2020

Avadel Pharmaceuticals plc Security Rating

/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Avadel Pharmaceuticals plc is implementing good security practices.

Company Information


About Avadel Pharmaceuticals plc

Avadel Pharmaceuticals plc NASDAQ: AVDL, is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel markets products in the hospital and primary care spaces.

Data Breaches and Security News

Security Report for Avadel Pharmaceuticals plc

Want a security rating for your organization?

This report shows a preliminary security rating for Avadel Pharmaceuticals plc. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Avadel Pharmaceuticals plc's security performance with other companies